Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Cardiotoxicity 5Neoplasms 3Breast Neoplasms 3Heart Failure 2Dyslipidemias 2Cardiovascular Diseases 2Ventricular Dysfunction, Left 1Thoracic Neoplasms 1Smoking 1Pulmonary Disease, Chronic Obstructive 1Overweight 1Obesity 1Noncommunicable Diseases 1Metabolic Syndrome 1Melanoma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hypokinesia 1Hypertension 1Hyperglycemia 1Diabetes Mellitus 1Coronary Disease 1Cerebrovascular Disorders 1Central Nervous System Neoplasms 1Cardiomyopathies 1Atrial Fibrillation 1Asthma 1Alcohol Drinking 1

Interventions

Blood Specimen Collection 2Vascular Stiffness 1Standard of Care 1Specimen Handling 1Pulse Wave Analysis 1Observation 1Electronic Health Records 1Electrocardiography 1Echocardiography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Cardiomyopathies × Electrocardiography × Clear all
NCT07041827 2025-06-27

CLARITY

The Netherlands Cancer Institute

Completed
217 enrolled
Lymphoid

Cardiovascular Diseases, Heart Failure, Lymphoma, Non-Hodgkin, Cardiomyopathies, Metabolic Syndrome, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡